RAIN logo

Rain Therapeutics (RAIN) Non Current Assets

Annual Non Current Assets

$1.55 M
+$558.00 K+56.14%

31 December 2022

RAIN Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$1.24 M
+$514.00 K+70.41%

30 September 2023

RAIN Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RAIN Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years-0.2%+10.6%
5 y5 years--

RAIN Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-0.2%-53.7%

Rain Therapeutics Non Current Assets History

DateAnnualQuarterly
Sept 2023
-
$1.24 M(+70.4%)
June 2023
-
$730.00 K(-39.3%)
Mar 2023
-
$1.20 M(-22.5%)
Dec 2022
$133.63 M
$1.55 M(+74.4%)
Sept 2022
-
$890.00 K(+16.2%)
June 2022
-
$766.00 K(-19.1%)
DateAnnualQuarterly
Mar 2022
-
$947.00 K(-4.7%)
Dec 2021
$146.15 M(+145.5%)
$994.00 K(-11.6%)
Sept 2021
-
$1.13 M(-13.1%)
June 2021
-
$1.29 M(-51.8%)
Mar 2021
-
$2.69 M(+72.7%)
Dec 2020
$59.52 M(+848.8%)
$1.55 M
Dec 2019
$6.27 M
-

FAQ

  • What is Rain Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Rain Therapeutics?
  • What is Rain Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Rain Therapeutics?

What is Rain Therapeutics annual long term assets?

The current annual non current assets of RAIN is $1.55 M

What is the all time high annual non current assets for Rain Therapeutics?

Rain Therapeutics all-time high annual long term assets is $1.55 M

What is Rain Therapeutics quarterly long term assets?

The current quarterly non current assets of RAIN is $1.24 M

What is the all time high quarterly non current assets for Rain Therapeutics?

Rain Therapeutics all-time high quarterly long term assets is $2.69 M